HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0350
-0.0010 (-2.78%)
Aug 28, 2026, 3:40 PM AEST
HeraMED Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.37 | 3.13 | 1.06 | 3.85 | 4.89 |
Short-Term Investments | - | - | 0.04 | 0.03 | 0.03 |
Cash & Short-Term Investments | 1.37 | 3.13 | 1.11 | 3.88 | 4.93 |
Cash Growth | -56.19% | 183.13% | -71.54% | -21.23% | 95.71% |
Accounts Receivable | - | 0.03 | 0.21 | 0.01 | 0 |
Other Receivables | 0.04 | 0.09 | 0.12 | 0.08 | 0.08 |
Receivables | 0.04 | 0.13 | 0.33 | 0.1 | 0.08 |
Inventory | - | 0.37 | 0.36 | 0.25 | 0.12 |
Prepaid Expenses | 0.04 | 0.05 | 0.13 | 0.12 | 0.16 |
Other Current Assets | - | - | - | 0.12 | 0.06 |
Total Current Assets | 1.45 | 3.68 | 1.93 | 4.48 | 5.35 |
Property, Plant & Equipment | 0 | 0.04 | 0.08 | 0.11 | 0.04 |
Long-Term Deferred Charges | - | 0.73 | 0.95 | 1.53 | 0.92 |
Other Long-Term Assets | 0.04 | 0.04 | - | - | - |
Total Assets | 1.49 | 4.48 | 2.95 | 6.12 | 6.31 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.11 | 0.3 | 0.36 | 0.22 | 0.22 |
Accrued Expenses | 0.17 | 0.36 | 0.4 | 0.51 | 0.73 |
Short-Term Debt | - | - | - | - | 4.43 |
Current Portion of Long-Term Debt | - | 0.08 | 0.26 | 0.26 | 0.27 |
Current Unearned Revenue | 0.04 | 0.31 | 0.49 | 0.17 | 0.05 |
Total Current Liabilities | 0.32 | 1.05 | 1.51 | 1.16 | 5.7 |
Long-Term Unearned Revenue | 0.24 | 0.66 | 0.76 | 0.74 | 0.76 |
Total Liabilities | 0.56 | 1.71 | 2.27 | 1.91 | 6.46 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 41.45 | 38.93 | 34.16 | 32.6 | 22.67 |
Retained Earnings | -44.18 | -46.33 | -40.84 | -35.66 | -26.62 |
Comprehensive Income & Other | 3.67 | 10.17 | 7.37 | 7.27 | 3.81 |
Shareholders' Equity | 0.93 | 2.77 | 0.69 | 4.21 | -0.15 |
Total Liabilities & Equity | 1.49 | 4.48 | 2.95 | 6.12 | 6.31 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0.08 | 0.26 | 0.26 | 4.7 |
Net Cash (Debt) | 1.37 | 3.05 | 0.84 | 3.62 | 0.23 |
Net Cash Growth | -55.01% | 260.76% | -76.68% | 1483.63% | -89.93% |
Net Cash Per Share | 0.00 | 0.01 | 0.00 | 0.02 | 0.00 |
Filing Date Shares Outstanding | 1,114 | 875.6 | 353.25 | 242.66 | 189.05 |
Total Common Shares Outstanding | 1,070 | 875.6 | 321.26 | 242.66 | 188.23 |
Working Capital | 1.13 | 2.62 | 0.42 | 3.31 | -0.35 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.02 | -0.00 |
Tangible Book Value | 0.93 | 2.77 | 0.69 | 4.21 | -0.15 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.02 | -0.00 |
Machinery | - | - | - | 0.2 | 0.1 |